Brief: Tonix Pharmaceuticals Announces Uplisting From Nasdaq Capital Market To Nasdaq Global Select Market
03/03/2026 11:26
March 3 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O: TONIX PHARMACEUTICALS ANNOUNCES UPLISTING FROM NASDAQ CAPITAL MARKET TO NASDAQ GLOBAL SELECT MARKET TONIX PHARMACEUTICALS - RECEIVED APPROVAL FROM NASDAQ TO TRANSFER LISTING FROM NASDAQ CAPITAL MARKET TO THE NASDAQ GLOBAL SELECT MARKET TONIX PHARMACEUTICALS - TRADING ON NASDAQ GLOBAL SELECT MARKET EXPECTED TO COMMENCE ON MARCH 3, UNDER COMPANY’S EXISTING TICKER SYMBOL “TNXP” Source text: ID:nGNX8JtNNY Further company coverage: TNXP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
Brief: Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement For Tonmya®
Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary
Tonix Q2 revenue rises sharply on TONMYA launch
Tonix Pharmaceuticals Holding Corp. expected to post a loss of $2.70 a share - Earnings Preview